問卷

TPIDB > Principal Investigator

Principal Investigator


Linkou Chang Gung Medical Foundation (在職)

Division of Nephrology

Division of General Internal Medicine

更新時間:2023-09-19

許翔皓HSU, HSIANG-HAO
  • Principal Investigator
  • Clinical Trial Experience (year) 17 years 9 個月
  • hsianghao@cgmh.org.tw

Publication

24Publications

21

(21) Tu YR, Tsai TY, Lin MS, Tu KH, Lee CC, Wu VC, Hsu HH, Chang MY, Tian YC, Chang CH*.
Association between initial dialytic modalities and the risks of mortality, infection death, and cardiovascular events: A nationwide population-based cohort study.
Sci Rep. 2020 May 15;10(1):8066.

22

(22) Weng CH, Li YJ, Wu HH, Liu SH, Hsu HH, Chen YC, Yang CW, Chu PH, Tian YC*.
Interleukin-17A induces renal fibrosis through the ERK and Smad signaling pathways.
Biomed Pharmacother. 2020 Mar;123:109741.

23

(23) Yang CW, Harris DCH, Luyckx VA, Nangaku M, Hou FF, Garcia Garcia G, Abu-Aisha H, Niang A, Sola L, Bunnag S, Eiam-Ong S, Tungsanga K, Richards M, Richards N, Goh BL, Dreyer G, Evans R, Mzingajira H, Twahir A, McCulloch MI, Ahn C, Osafo C, Hsu HH, Barnieh L, Donner JA, Tonelli M*.
Global case studies for chronic kidney disease/end-stage kidney disease care.
Kidney Int Suppl (2011). 2020 Mar;10(1):e24-e48.

24

(24) Tsai CH, Hsu HH, Chen SH, Chien L, Lin JA, Chang CJ, Kao HK*.
Incidence and Risk of Carpal Tunnel Syndrome in End-Stage Renal Disease Patients on Dialysis: A Nationwide Population-Based Matched Cohort Study.
Ann Plast Surg. 2020 Jan;84(1S Suppl 1):S100-S106.
1 2 3